Houston Corporate Shareholders Stuart Miller and Daniel Sternthal present at the ASKP3 Annual Conference on Friday, January 30th. Their presentation entitled “Staying Compliant: Essential Legal Updates for Your Ketamine Practice” will address critical regulatory changes affecting ketamine clinic operations, including recent updates related to the FDA, DEA, state licensing regulations, case laws & clinical practice guidelines. Attendees will learn about documentation standards, patient consent protocols, and liability considerations that directly impact operations. The session covers practical compliance strategies, risk mitigation techniques, and operational adjustments needed to maintain regulatory standing while protecting your practice from legal exposure. Topics include consents, staff training, and emerging best practices for quality assurance programs. Designed for clinic owners and operators, this overview provides actionable guidance to ensure your ketamine practice remains compliant with evolving legal standards.

To register for the conference, click here.